EMA recommends Leqembi for treatment of early Alzheimer’s disease
PremiumThe FlyEMA recommends Leqembi for treatment of early Alzheimer’s disease
3d ago
Biogen up 5% after EMA recommends Leqembi for early Alzheimer’s disease
Premium
The Fly
Biogen up 5% after EMA recommends Leqembi for early Alzheimer’s disease
3d ago
American upgraded, Regeneron initiated: Wall Street’s top analyst calls
Premium
The Fly
American upgraded, Regeneron initiated: Wall Street’s top analyst calls
3d ago
VOO ETF Update, 11/8/2024  
PremiumMarket NewsVOO ETF Update, 11/8/2024  
9d ago
SPY ETF Update, 11/7/2024 
Premium
Market News
SPY ETF Update, 11/7/2024 
10d ago
QQQ ETF Update, 11/6/2024 
Premium
Market News
QQQ ETF Update, 11/6/2024 
11d ago
Biogen price target lowered to $275 from $300 at TD Cowen
PremiumThe FlyBiogen price target lowered to $275 from $300 at TD Cowen
17d ago
Biogen price target lowered to $180 from $190 at Barclays
Premium
The Fly
Biogen price target lowered to $180 from $190 at Barclays
17d ago
Biogen downgraded to Equal Weight from Overweight at Morgan Stanley
Premium
The Fly
Biogen downgraded to Equal Weight from Overweight at Morgan Stanley
17d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100